Copyright Reports & Markets. All rights reserved.

Global Artificial Blood Substitute Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Artificial Blood Substitute Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Artificial Blood Substitute Market Size Growth Rate by Type
    • 1.4.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
    • 1.4.3 Hemoglobin-based Oxygen Carrier (HBOC)
  • 1.3 Market by Application
    • 1.3.1 Global Artificial Blood Substitute Market Size Growth Rate by Application
    • 1.3.2 Military
    • 1.3.3 Civil
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Artificial Blood Substitute Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Artificial Blood Substitute Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Artificial Blood Substitute Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Artificial Blood Substitute Regions by Sales
    • 2.4.1 Global Top Artificial Blood Substitute Regions by Sales (2016-2021)
    • 2.4.2 Global Top Artificial Blood Substitute Regions by Sales (2022-2027)
  • 2.5 Global Top Artificial Blood Substitute Regions by Revenue
    • 2.5.1 Global Top Artificial Blood Substitute Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Artificial Blood Substitute Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Artificial Blood Substitute Sales by Manufacturers
    • 3.1.1 Global Top Artificial Blood Substitute Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Artificial Blood Substitute Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Artificial Blood Substitute Sales in 2020
  • 3.2 Global Artificial Blood Substitute Revenue by Manufacturers
    • 3.2.1 Global Top Artificial Blood Substitute Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Artificial Blood Substitute Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Artificial Blood Substitute Revenue in 2020
  • 3.3 Global Artificial Blood Substitute Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Artificial Blood Substitute Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Artificial Blood Substitute Sales by Type
    • 4.1.1 Global Artificial Blood Substitute Historical Sales by Type (2016-2021)
    • 4.1.2 Global Artificial Blood Substitute Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Artificial Blood Substitute Sales Market Share by Type (2016-2027)
  • 4.2 Global Artificial Blood Substitute Revenue by Type
    • 4.2.1 Global Artificial Blood Substitute Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Artificial Blood Substitute Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Artificial Blood Substitute Revenue Market Share by Type (2016-2027)
  • 4.3 Global Artificial Blood Substitute Price by Type
    • 4.3.1 Global Artificial Blood Substitute Price by Type (2016-2021)
    • 4.3.2 Global Artificial Blood Substitute Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Artificial Blood Substitute Sales by Application
    • 5.1.1 Global Artificial Blood Substitute Historical Sales by Application (2016-2021)
    • 5.1.2 Global Artificial Blood Substitute Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Artificial Blood Substitute Sales Market Share by Application (2016-2027)
  • 5.2 Global Artificial Blood Substitute Revenue by Application
    • 5.2.1 Global Artificial Blood Substitute Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Artificial Blood Substitute Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Artificial Blood Substitute Revenue Market Share by Application (2016-2027)
  • 5.3 Global Artificial Blood Substitute Price by Application
    • 5.3.1 Global Artificial Blood Substitute Price by Application (2016-2021)
    • 5.3.2 Global Artificial Blood Substitute Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Artificial Blood Substitute Market Size by Type
    • 6.1.1 North America Artificial Blood Substitute Sales by Type (2016-2027)
    • 6.1.2 North America Artificial Blood Substitute Revenue by Type (2016-2027)
  • 6.2 North America Artificial Blood Substitute Market Size by Application
    • 6.2.1 North America Artificial Blood Substitute Sales by Application (2016-2027)
    • 6.2.2 North America Artificial Blood Substitute Revenue by Application (2016-2027)
  • 6.3 North America Artificial Blood Substitute Market Size by Country
    • 6.3.1 North America Artificial Blood Substitute Sales by Country (2016-2027)
    • 6.3.2 North America Artificial Blood Substitute Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Artificial Blood Substitute Market Size by Type
    • 7.1.1 Europe Artificial Blood Substitute Sales by Type (2017-2027)
    • 7.1.2 Europe Artificial Blood Substitute Revenue by Type (2017-2027)
  • 7.2 Europe Artificial Blood Substitute Market Size by Application
    • 7.2.1 Europe Artificial Blood Substitute Sales by Application (2017-2027)
    • 7.2.2 Europe Artificial Blood Substitute Revenue by Application (2017-2027)
  • 7.3 Europe Artificial Blood Substitute Market Size by Country
    • 7.3.1 Europe Artificial Blood Substitute Sales by Country (2017-2027)
    • 7.3.2 Europe Artificial Blood Substitute Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Artificial Blood Substitute Market Size by Type
    • 8.1.1 Asia Pacific Artificial Blood Substitute Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Artificial Blood Substitute Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Artificial Blood Substitute Market Size by Application
    • 8.2.1 Asia Pacific Artificial Blood Substitute Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Artificial Blood Substitute Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Artificial Blood Substitute Market Size by Region
    • 8.3.1 Asia Pacific Artificial Blood Substitute Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Artificial Blood Substitute Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Artificial Blood Substitute Market Size by Type
    • 9.1.1 Latin America Artificial Blood Substitute Sales by Type (2019-2027)
    • 9.1.2 Latin America Artificial Blood Substitute Revenue by Type (2019-2027)
  • 9.2 Latin America Artificial Blood Substitute Market Size by Application
    • 9.2.1 Latin America Artificial Blood Substitute Sales by Application (2019-2027)
    • 9.2.2 Latin America Artificial Blood Substitute Revenue by Application (2019-2027)
  • 9.3 Latin America Artificial Blood Substitute Market Size by Country
    • 9.3.1 Latin America Artificial Blood Substitute Sales by Country (2019-2027)
    • 9.3.2 Latin America Artificial Blood Substitute Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Artificial Blood Substitute Market Size by Type
    • 6.1.1 Middle East and Africa Artificial Blood Substitute Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Artificial Blood Substitute Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Artificial Blood Substitute Market Size by Application
    • 6.2.1 Middle East and Africa Artificial Blood Substitute Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Artificial Blood Substitute Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Artificial Blood Substitute Market Size by Country
    • 6.3.1 Middle East and Africa Artificial Blood Substitute Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Artificial Blood Substitute Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 UAE

11 Company Profiles

  • 11.1 Aurum Biosciences Ltd.
    • 11.1.1 Aurum Biosciences Ltd. Corporation Information
    • 11.1.2 Aurum Biosciences Ltd. Overview
    • 11.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Product Description
    • 11.1.5 Aurum Biosciences Ltd. Related Developments
  • 11.2 HEMARINA SA
    • 11.2.1 HEMARINA SA Corporation Information
    • 11.2.2 HEMARINA SA Overview
    • 11.2.3 HEMARINA SA Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 HEMARINA SA Artificial Blood Substitute Product Description
    • 11.2.5 HEMARINA SA Related Developments
  • 11.3 HbO2 Therapeutics
    • 11.3.1 HbO2 Therapeutics Corporation Information
    • 11.3.2 HbO2 Therapeutics Overview
    • 11.3.3 HbO2 Therapeutics Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 HbO2 Therapeutics Artificial Blood Substitute Product Description
    • 11.3.5 HbO2 Therapeutics Related Developments
  • 11.4 KaloCyte Inc.
    • 11.4.1 KaloCyte Inc. Corporation Information
    • 11.4.2 KaloCyte Inc. Overview
    • 11.4.3 KaloCyte Inc. Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 KaloCyte Inc. Artificial Blood Substitute Product Description
    • 11.4.5 KaloCyte Inc. Related Developments
  • 11.5 SpheriTech Ltd.
    • 11.5.1 SpheriTech Ltd. Corporation Information
    • 11.5.2 SpheriTech Ltd. Overview
    • 11.5.3 SpheriTech Ltd. Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 SpheriTech Ltd. Artificial Blood Substitute Product Description
    • 11.5.5 SpheriTech Ltd. Related Developments
  • 11.6 NuvOx Pharma
    • 11.6.1 NuvOx Pharma Corporation Information
    • 11.6.2 NuvOx Pharma Overview
    • 11.6.3 NuvOx Pharma Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 NuvOx Pharma Artificial Blood Substitute Product Description
    • 11.6.5 NuvOx Pharma Related Developments
  • 11.1 Aurum Biosciences Ltd.
    • 11.1.1 Aurum Biosciences Ltd. Corporation Information
    • 11.1.2 Aurum Biosciences Ltd. Overview
    • 11.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Product Description
    • 11.1.5 Aurum Biosciences Ltd. Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Artificial Blood Substitute Value Chain Analysis
  • 12.2 Artificial Blood Substitute Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Artificial Blood Substitute Production Mode & Process
  • 12.4 Artificial Blood Substitute Sales and Marketing
    • 12.4.1 Artificial Blood Substitute Sales Channels
    • 12.4.2 Artificial Blood Substitute Distributors
  • 12.5 Artificial Blood Substitute Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Artificial Blood Substitute Industry Trends
  • 13.2 Artificial Blood Substitute Market Drivers
  • 13.3 Artificial Blood Substitute Market Challenges
  • 13.4 Artificial Blood Substitute Market Restraints

14 Key Findings in The Global Artificial Blood Substitute Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Artificial Blood Substitute market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Blood Substitute market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Perfluorocarbon-based Oxygen Carrier (PFBOC)
    Hemoglobin-based Oxygen Carrier (HBOC)

    Segment by Application
    Military
    Civil

    By Company
    Aurum Biosciences Ltd.
    HEMARINA SA
    HbO2 Therapeutics
    KaloCyte Inc.
    SpheriTech Ltd.
    NuvOx Pharma

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now